Simone Oppenheimer
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Angiogenesis and VEGF in Cancer, Monoclonal and Polyclonal Antibodies Research, Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms
Most-Cited Works
- → Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily(2009)275 cited
- → A novel family of T-box genes in urodele amphibian limb development and regeneration: candidate genes involved in vertebrate forelimb/hindlimb patterning(1997)86 cited
- → Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling(2006)79 cited
- → Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance(2019)58 cited
- → New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases(2007)38 cited
- → 5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases(2007)30 cited
- → Discovery and Preclinical Evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic Acid, (3S)-3-Morpholinylmethyl Ester (BMS-599626), a Selective and Orally Efficacious Inhibitor of Human Epidermal Growth Factor Receptor 1 and 2 Kinases(2009)30 cited
- Identification of differentially expressed messenger RNAs in human melanocytes and melanoma cells.(1996)
- → Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases(2007)28 cited
- → Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinases(2010)27 cited